Molecular MRI Biomarker Program

This program seeks to advance the development of innovative molecular MRI (mMRI) techniques that directly quantify molecular and cellular events in Parkinson’s disease (PD). Full proposals that focus on the following molecular and cellular pathways associated with PD are invited to apply:  

• Endolysosomal Dysfunction
• Mitochondrial Impairment
• Neuroinflammation & Immune System Dysregulation

Funding: $400,000 total 

Duration: 2 years

Research Authority due date: 07.7.25

Full proposal due date: 14.7.25